Financials SeqLL Inc.

Equities

SEQL

US81734C3043

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 10:08:23 2024-04-26 am EDT 5-day change 1st Jan Change
1.3 USD 0.00% Intraday chart for SeqLL Inc. -23.53% -68.52%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 22.23 3.455 1.572
Enterprise Value (EV) 1 13.65 0.1683 1.809
P/E ratio -3.64 x -0.84 x -0.27 x
Yield - - -
Capitalization / Revenue 106 x 43.9 x -
EV / Revenue 65 x 2.14 x -
EV / EBITDA -8.58 x -0.04 x -0.32 x
EV / FCF -19.2 x -0.07 x -0.61 x
FCF Yield -5.2% -1,342% -165%
Price to Book 2.72 x 0.79 x 2.59 x
Nbr of stocks (in thousands) 297 297 381
Reference price 2 74.80 11.63 4.130
Announcement Date 3/23/22 3/16/23 4/10/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.7791 0.5331 0.3295 0.21 0.0787 -
EBITDA 1 -2.338 -2.17 -0.841 -1.592 -3.909 -5.578
EBIT 1 -2.401 -2.291 -0.9497 -1.679 -3.997 -5.733
Operating Margin -308.23% -429.78% -288.24% -799.37% -5,081.62% -
Earnings before Tax (EBT) 1 -2.888 -2.474 -1.045 -3.704 -4.095 -5.628
Net income 1 -2.888 -2.474 -1.045 -3.704 -4.095 -5.628
Net margin -370.7% -463.97% -317.26% -1,763.64% -5,205.8% -
EPS 2 -23.75 -20.34 -8.595 -20.53 -13.78 -15.03
Free Cash Flow 1 -1.155 -0.232 -0.7726 -0.7094 -2.258 -2.988
FCF margin -148.2% -43.52% -234.48% -337.83% -2,870.65% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/23/19 3/31/21 3/31/21 3/23/22 3/16/23 4/10/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 0.035 - - - -
EBITDA - - - - -
EBIT 1 -1.372 - -0.9185 -1.245 -1.758
Operating Margin -3,924.02% - - - -
Earnings before Tax (EBT) 1 -1.397 - -0.926 -1.236 -1.718
Net income 1 -1.397 -0.9949 -0.926 -1.236 -1.718
Net margin -3,995.25% - - - -
EPS 2 -4.000 -3.200 -3.200 -4.000 -5.200
Dividend per Share - - - - -
Announcement Date 3/23/22 8/12/22 11/8/22 3/16/23 5/9/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.93 2.52 3.56 - - 0.24
Net Cash position 1 - - - 8.57 3.29 -
Leverage (Debt/EBITDA) -0.3989 x -1.16 x -4.236 x - - -0.0424 x
Free Cash Flow 1 -1.15 -0.23 -0.77 -0.71 -2.26 -2.99
ROE (net income / shareholders' equity) 270% 154% 31.3% -171% -65.3% -226%
ROA (Net income/ Total Assets) -133% -138% -75% -18.4% -26.1% -55.8%
Assets 1 2.174 1.787 1.393 20.18 15.7 10.09
Book Value Per Share 2 -3.180 -23.30 -31.70 27.50 14.70 1.600
Cash Flow per Share 2 0.5300 0.0500 - 13.50 7.340 7.080
Capex - - - 0.01 0.04 0.06
Capex / Sales - - - 6.89% 50.88% -
Announcement Date 4/23/19 3/31/21 3/31/21 3/23/22 3/16/23 4/10/24
1USD in Million2USD
Estimates